相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Platinum-DNA Interactions and Subsequent Cellular Processes Controlling Sensitivity to Anticancer Platinum Complexes
Saeed Ahmad
CHEMISTRY & BIODIVERSITY (2010)
The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin
Anamaria Brozovic et al.
CRITICAL REVIEWS IN TOXICOLOGY (2010)
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer
Trudy G. Oliver et al.
GENES & DEVELOPMENT (2010)
Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non-Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study
Glenwood D. Goss et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Differential Roles for DNA Polymerases Eta, Zeta, and REV1 in Lesion Bypass of Intrastrand versus Interstrand DNA Cross-Links
J. Kevin Hicks et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Error-prone translesion synthesis mediates acquired chemoresistance
Kun Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Expression of MRP1, BCRP, LRP and ERCC1 in Advanced Non-Small-Cell Lung Cancer: Correlation With Response to Chemotherapy and Survival
Jian Li et al.
CLINICAL LUNG CANCER (2009)
Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals
Sigal Shachar et al.
EMBO JOURNAL (2009)
Polζ ablation in B cells impairs the germinal center reaction, class switch recombination, DNA break repair, and genome stability
Dominik Schenten et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression
Corbin E. Meacham et al.
NATURE GENETICS (2009)
REV3L confers chemoresistance to cisplatin in human gliomas: The potential of its RNAi for synergistic therapy
Huibo Wang et al.
NEURO-ONCOLOGY (2009)
Eukaryotic Translesion Polymerases and Their Roles and Regulation in DNA Damage Tolerance
Lauren S. Waters et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2009)
Mechanism of replication-coupled DNA interstrand crosslink repair
Markus Raeschle et al.
CELL (2008)
Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol ζ
J-M Brondello et al.
ONCOGENE (2008)
Topoisomerase levels determine chemotherapy response in vitro and in vivo
Darren J. Burgess et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
DNA polymerase zeta (pol zeta) in higher eukaryotes
Gregory N. Gan et al.
CELL RESEARCH (2008)
Direct cellular responses to platinum-induced DNA damage
Yongwon Jung et al.
CHEMICAL REVIEWS (2007)
Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions
Steven R. Bartz et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistance
Xinjian Lin et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Human REV1 modulates the cytotoxicity and mutagenicity of cisplatin in human ovarian carcinoma cells
XJ Lin et al.
MOLECULAR PHARMACOLOGY (2006)
Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells
JP Wittschieben et al.
CANCER RESEARCH (2006)
Model organisms - The mighty mouse: genetically engineered mouse models in cancer drug development
Norman E. Sharpless et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells
K Nojima et al.
CANCER RESEARCH (2005)
Suppression of hREV1 expression reduces the rate at which human ovarian carcinoma cells acquire resistance to cisplatin
T Okuda et al.
MOLECULAR PHARMACOLOGY (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
DNA interstrand crosslinks: Natural and drug-induced DNA adducts that induce unique cellular responses
OD Scharer
CHEMBIOCHEM (2005)
DNA polymerase ζ regulates cisplatin cytotoxicity, mutagenicity, and the rate of development of cisplatin resistance
F Wu et al.
CANCER RESEARCH (2004)
Cisplatin biochemical mechanism of action:: From cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways
MA Fuertes et al.
CURRENT MEDICINAL CHEMISTRY (2003)
hREV3 is essential for error-prone translesion synthesis past UV or benzo[a]pyrene diol epoxide-induced DNA lesions in human fibroblasts
ZQ Li et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2002)
Advanced presentation of lung cancer in Asian immigrants - A case-control study
GA Finlay et al.
CHEST (2002)
Cancer Modeling in the modern era: Progress and challenges
T Van Dyke et al.
CELL (2002)
分享论文
